BioSpace News Archive

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, will host a conference call on Monday, November 14, 2022, at 8:30 AM ET to report its financial results for the third quarter of 2022.

Intelligent Bio Solutions Inc. announced that UK insulated glass manufacturer Glass Systems is adopting the latest fingerprint-based drug testing system to promote health and safety across the business.

Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its third quarter 2022 financial results and provide a corporate update on Monday, November 14, 2022.

Dyadic International, Inc. announced that its management and representatives will participate in the following upcoming industry and investor events in November 2022.

T2 Biosystems, Inc. announced that the U.S. Department of Health and Human Services and the Steven & Alexandra Cohen Foundation have selected T2 Biosystems as a Phase 1 winner in the LymeX Diagnostics Prize, a LymeX Innovation Accelerator prize competition to accelerate the development of Lyme disease diagnostics.

Albireo Pharma, Inc. (Nasdaq: ALBO), a rare disease company developing novel bile acid modulators to treat pediatric and adult liver diseases, presented new data at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2022, being held November 4 – 8, 2022 in Washington, D.C.

Xenon Pharmaceuticals Inc., a neurology-focused biopharmaceutical company, announced the appointment of Andrea DiFabio as Chief Legal Officer and Corporate Secretary, effective immediately.

Theralink Technologies, Inc. announced that it has appointed Dr. Mattia Cremona as its Director of its Biopharma Laboratory effective November 7, 2022.

Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced it will present preclinical data highlighting its recent cytoDRiVE® platform and pipeline advances during the poster sessions at the upcoming SITC Annual Meeting 2022.

DiaMedica Therapeutics Inc. announced that Rick Pauls, its President and CEO will be participating in the 13th Annual Craig-Hallum Alpha Select Conference being held in New York on Thursday, November 17, 2022.